These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33673088)

  • 1. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
    Ghanbari-Movahed M; Ghanbari-Movahed Z; Momtaz S; Kilpatrick KL; Farzaei MH; Bishayee A
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33673088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Evaluation of Clinical Candidates of γ-Secretase Inhibitors: Effects on Notch Inhibition and Promoting Beige Adipogenesis and Mitochondrial Biogenesis.
    Huang D; Qiu J; Kuang S; Deng M
    Pharm Res; 2020 Sep; 37(10):185. PubMed ID: 32888109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
    Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
    Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules that inhibit Notch signaling.
    De Kloe GE; De Strooper B
    Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance.
    McCaw TR; Inga E; Chen H; Jaskula-Sztul R; Dudeja V; Bibb JA; Ren B; Rose JB
    Oncologist; 2021 Apr; 26(4):e608-e621. PubMed ID: 33284507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M; Osipo C
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells.
    Nasrin A; Hassan M; Ye P
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2118-2124. PubMed ID: 29253571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
    Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct.
    Ran Y; Hossain F; Pannuti A; Lessard CB; Ladd GZ; Jung JI; Minter LM; Osborne BA; Miele L; Golde TE
    EMBO Mol Med; 2017 Jul; 9(7):950-966. PubMed ID: 28539479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atonal homolog 1 is required for growth and differentiation effects of notch/gamma-secretase inhibitors on normal and cancerous intestinal epithelial cells.
    Kazanjian A; Noah T; Brown D; Burkart J; Shroyer NF
    Gastroenterology; 2010 Sep; 139(3):918-28, 928.e1-6. PubMed ID: 20621629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH signaling as a novel cancer therapeutic target.
    Miele L; Miao H; Nickoloff BJ
    Curr Cancer Drug Targets; 2006 Jun; 6(4):313-23. PubMed ID: 16848722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling.
    Das A; Narayanam MK; Paul S; Mukhnerjee P; Ghosh S; Dastidar DG; Chakrabarty S; Ganguli A; Basu B; Pal M; Chatterji U; Banerjee SK; Karmakar P; Kumar D; Chakrabarti G
    J Biol Chem; 2019 Apr; 294(17):6733-6750. PubMed ID: 30824542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance.
    Feng M; Santhanam RK; Xing H; Zhou M; Jia H
    Biochem Pharmacol; 2024 Feb; 220():115991. PubMed ID: 38135129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors.
    Mamaeva V; Niemi R; Beck M; Özliseli E; Desai D; Landor S; Gronroos T; Kronqvist P; Pettersen IK; McCormack E; Rosenholm JM; Linden M; Sahlgren C
    Mol Ther; 2016 May; 24(5):926-36. PubMed ID: 26916284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.